Skip to main content

Table 1 Patient and adrenal metastasis characteristics

From: Percutaneous radiofrequency ablation of adrenal metastases from hepatocellular carcinoma: a single-center experience

Characteristics Value (n = 22)
Patient characteristics
Sex
 Male 21
 Female 1
Age, yeara 52 (33–75)
Hepatitis
 Yes 19
 No 3
Previous HCC treatment
 Resection 17
 Transplantation 3
 Ablation 2
AFP (μg/L)
  ≤ 400 15
  > 400 7
Cirrhosis
 Yes 10
 No 12
Child-Pugh class
 A 19
 B 3
ECOG Performance Status
 0 20
 1 2
Tumour characteristics
Time to adrenal metastases
 Synchronous (≤ 6 months) 6
 Metachronous (>  6 months) 16
Extent of disease at time of ablation
 Isolated AM 11
 rHCC and AM 9
 Metastases in other sites 2
Tumour size
  ≤ 5 cm 17
  > 5 cm 5
Laterality
 Right 20
 Left 2
  1. amedian (range), HCC hepatocellular carcinoma, AFP alpha-fetoprotein, ECOG Eastern Cooperative Oncology Group, AM adrenal metastasis, rHCC recurrent hepatocellular carcinoma